Neuroscience Institute

What Neuroscience Institute does

Neuroscience Institute is a privately held, multi-state behavioral health operator founded in 2002 and headquartered in West Palm Beach, Florida, with additional offices in Oklahoma and New York. The organization delivers outpatient and residential mental health treatment across a full acuity continuum — residential, partial hospitalization (PHP), intensive outpatient (IOP), and standard outpatient — using an integrated modality stack that includes transcranial magnetic stimulation (TMS), neurofeedback, EMDR, CBT, and DBT, supplemented by holistic services such as yoga, meditation, and nutritional therapy. The Institute runs specialty programs in dual diagnosis, deprescribing, and healthcare professional mental health, and maintains an active clinical research arm in which founder Dr. Danesh Alam has served as principal investigator on more than 40 studies across Alzheimer's disease, GLP-1 receptor agonists for opioid use disorder, schizophrenia, bipolar disorder, and treatment-resistant depression.

The business model is built on insurance-reimbursed clinical delivery, with in-network relationships with UnitedHealthcare and Horizon Blue Cross Blue Shield, supplemented by telehealth services to extend reach beyond the three physical locations. Founded and led by Dr. Alam, an internationally recognized psychiatrist with academic appointments at Northwestern University and the University of Illinois at Chicago, the Institute has reportedly served more than 10,000 clients over its 22+ year history. Operational scale is modest — 11-50 employees — placing it in the regional specialty provider category rather than national chain territory.

Revenue is not publicly disclosed and the organization appears to be bootstrapped, with no external funding rounds identified in the input data. Competitive positioning rests on the founder's clinical-research reputation, multi-state licensure, payor credentialing, and a differentiated clinical-trial portfolio in high-priority therapeutic areas, rather than on technology differentiation or scale economics.

Name

Neuroscience Institute

Legal name

Neuroscience Institute

Website

https://neuroscienceresearchinstitute.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Neuroscience Institute is a multi-state outpatient and residential mental health provider founded in 2002 and led by Dr. Danesh Alam, serving patients in Florida, Oklahoma, and New York via insurance-reimbursed clinical programs and active psychiatric clinical research.

Ownership category

akta.pro rank

Product category

Mental Health Treatment Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Residential Mental Health and Substance Abuse Facilities (62322), Offices of Physicians, Mental Health Specialists (621112)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Nursing & Personal Care Facilities (8050)

akta.pro primary industry

Psychiatry & Medication Management Platforms (HLALAEAB)

Keywords

• Mental health treatment
• Behavioral health services
• Residential treatment programs
• Psychiatric evaluation services
• Clinical research trials

Headquarters

HQ city

West Palm Beach

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Insurance-Reimbursed Mental Health Services: Residential treatment, partial hospitalization (PHP), intensive outpatient (IOP), and outpatient mental health services billed through patient insurance plans. Accepts major insurance providers including UnitedHealthcare and Horizon Blue Cross Blue Shield. Revenue generated through reimbursement for covered mental health treatment services as required by the Affordable Care Act's essential health benefits.
2. Clinical Research Trials: Research programs investigating treatments for Alzheimer's, depression, bipolar disorder, schizophrenia, and GLP-1 for opioid use disorder. Participants receive study-related care while contributing to scientific advancement. Studies include comprehensive assessments, regular monitoring, and access to investigational approaches.
3. Specialty Mental Health Programs: Specialized treatment programs including healthcare professional mental health services, dual diagnosis treatment, and deprescribing programs. These niche services address specific populations with tailored therapeutic approaches.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Neuroscience Institute is a private, physician-led mental health treatment center that provides a continuum of behavioral health care including residential treatment, partial hospitalization (PHP), intensive outpatient (IOP), and outpatient programs. Services are delivered alongside advanced therapeutic modalities such as Transcranial Magnetic Stimulation (TMS), neurofeedback, EMDR, CBT, DBT, and holistic treatment, supported by an active clinical research division running trials in Alzheimer's, depression, bipolar disorder, schizophrenia, and GLP-1/opioid use.

Product overview

The Neuroscience Institute is a private, physician-led mental health treatment center offering a comprehensive continuum of care through multiple service levels and therapeutic modalities. The organization operates a multi-level treatment model including Mental Health Residential Treatment, Partial Hospitalization (PHP), and Intensive Outpatient (IOP) programs, complemented by specialized therapeutic modalities such as Neurofeedback, EMDR Therapy, TMS (Transcranial Magnetic Stimulation), Trauma Therapy, and Holistic Treatment. The institute provides clinical programs addressing specific disorders including Depression, Anxiety, Bipolar Disorder, PTSD & Trauma, OCD, Schizophrenia, Borderline Personality, Dual Diagnosis, Self-Harm, and Thought Disorders. Additionally, the organization operates an active research division conducting clinical trials in Alzheimer's treatment, GLP1 and Opioid Use, Schizophrenia, Bipolar Disorder, and Depression. Services are delivered across multiple locations (South Florida, Oklahoma, New York) with insurance partnerships including UnitedHealthcare and Horizon Blue Cross Blue Shield.

Differentiator

Problem solved

Functional benefit

Products and services

• Mental Health Residential Treatment Inpatient residential program for individuals living with mental health disorders such as PTSD, bipolar disorder, depression, or anxiety, providing comprehensive, evidence-based treatment in a supportive 24/7 care environment.
• Partial Hospitalization Program (PHP) Day-treatment outpatient program offering structured clinical care for clients stepping down from residential treatment or requiring more support than standard outpatient care.
• Intensive Outpatient Program (IOP) Structured intensive outpatient treatment to support clients with behavioral health disorders, providing a step-down level of care with multiple weekly sessions.
• TMS Services (Transcranial Magnetic Stimulation) Non-invasive neuromodulation treatment using targeted magnetic pulses to stimulate specific areas of the brain involved in mood, emotion, and cognitive regulation, primarily used for treatment-resistant depression.
• Neurofeedback Therapy Evidence-based brain training treatment that helps retrain the brain to achieve relief from mental illness symptoms by monitoring and modulating brain wave activity.
• EMDR Therapy Eye Movement Desensitization and Reprocessing therapy for PTSD that enables individuals to safely overcome trauma through bilateral stimulation techniques.
• Cognitive Behavioral Therapy (CBT) Evidence-based psychotherapy approach delivered in individual, group, and family settings to address maladaptive thoughts and behaviors associated with mental health disorders.
• Dialectical Behavior Therapy (DBT) Specialized cognitive behavioral treatment combining cognitive behavioral techniques with mindfulness for borderline personality disorder, self-harm, suicidal ideation, and emotional dysregulation.
• Trauma Therapy Specialized therapeutic approaches, including EMDR, designed to help individuals process and heal from traumatic experiences and PTSD.
• Holistic Treatment Program Integrated treatment addressing mind, body, and spirit through modalities such as yoga, meditation, and nutritional therapy to complement psychological treatment.
• Dual Diagnosis Treatment Comprehensive residential program for clients with co-occurring mental health disorders and substance abuse or misuse issues, providing integrated treatment of both conditions.
• Psychiatry and Psychiatric Evaluations Comprehensive psychiatric assessments and evaluations to determine appropriate treatment pathways, including medication management for mental health conditions.
• Deprescribing Medications Program Systematic process of tapering or discontinuing mental health medications that may no longer be beneficial, addressing polypharmacy and reducing adverse effects.
• Healthcare Professionals Mental Health Treatment Specialized mental health treatment program addressing burnout, depression, PTSD, and other mental health disorders affecting healthcare workers, including pandemic-related stress.
• Mental Health Assessments Self-assessment tools for depression and anxiety, providing individuals with preliminary insights to determine whether professional mental health help may be beneficial.
• Alzheimer's Treatment Research Program Research program advancing Alzheimer's treatment through neuroscience-driven approaches combining advanced diagnostics, neuroplasticity science, and non-invasive neuromodulation.
• GLP-1 and Opioid Use Research Study Pioneering research exploring how GLP-1 therapies can reshape brain reward circuits, reduce cravings, and lower relapse risk for opioid use disorder.
• Schizophrenia Research Study Clinical research study evaluating innovative therapies to improve symptoms, cognition, and quality of life for individuals living with schizophrenia.
• Bipolar Disorder Research Study Research program advancing precision, neurobiology-driven, and personalized care models for bipolar disorder treatment.
• Depression Treatment Research Study Research study advancing science-driven, personalized approaches to depression care through innovative clinical studies and neuroscience-based methodologies.

Quantifiable outcome

• 10,000+ clients have achieved recovery and maintained mental health improvements through the institute's treatment programs

Named customers2 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

Four partnerships are on record, tiered minor and core.

• NovaWell (Horizon BCBS Initiative)minorStrategic or Co-development Partner · 1 November 2022Horizon BCBS launched NovaWell behavioral health integration service in November 2022. Uses data analysis to direct members to mental health services and identify healthcare gaps. Represents Horizon's leadership in integrating behavioral health into primary care.
• UnitedHealthcarecoreChannel Partner/ Reseller/ DistributorNeuroscience Institute is a UnitedHealthcare-partnered mental health facility in West Palm Beach, FL. Accepts UHC insurance plans for residential, partial hospitalization, outpatient, and telehealth mental health services. Partnership enables covered treatment access for UHC members seeking mental health care.
• Horizon Blue Cross Blue Shield of New JerseycoreChannel Partner/ Reseller/ DistributorProud partner of Horizon BCBS of New Jersey providing rehab and mental health treatment services. Accepts various Horizon plan types including BlueCard PPO, EPO, HMO, POS, OMNIA Health Plans, and Traditional Indemnity. Covers behavioral health treatment, dual diagnosis, and substance use disorder services for Horizon members.
• Ambrosia Behavioral HealthminorOthersRelated treatment center and resource partner providing additional mental health and addiction treatment services. Referenced as affiliated organization in research study resources.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Geode Health: Multi-state outpatient mental health provider combining in-person psychiatry, therapy, and TMS services. Comparable integrated outpatient psychiatry + neuromodulation model targeting insured patients.
• Cerebral: Telehealth mental health company providing online psychiatry and therapy for anxiety, depression, and ADHD. Comparable tele-psychiatry and medication management delivery, though Cerebral has faced regulatory and operational turbulence.
• Mindpath Health: Outpatient psychiatric and therapy practice network offering medication management, TMS, and psychotherapy across multiple states. Comparable multi-state outpatient psychiatry footprint with neuromodulation offering.
• Brightside Health: Telehealth mental health platform specializing in anxiety and depression treatment with medication management and therapy. Comparable tele-psychiatry model for insured behavioral health populations.
• Greenbrook TMS: Specialty provider of Transcranial Magnetic Stimulation therapy for depression and other mental health conditions. Directly comparable TMS-led treatment offering targeting treatment-resistant patients.
• Talkiatry: Insurance-based psychiatry and medication management platform offering in-network telehealth and in-person visits. Comparable psychiatry, medication management, and telehealth delivery for mood and anxiety disorders.
• Amen Clinics: Multi-site psychiatric practice combining brain imaging, neuromodulation (TMS), and clinical psychiatry for mood and behavioral disorders. Comparable neuroscience-driven, physician-led approach with multi-state footprint.
• Newport Healthcare: Operates residential and outpatient mental health treatment programs for adolescents and adults, including mood, anxiety, trauma, and co-occurring disorders. Directly comparable continuum-of-care model with multi-state facility footprint.
• Pasadena Villa: Residential mental health treatment centers serving adults with mood, anxiety, psychotic, and co-occurring disorders. Comparable residential treatment model with similar therapeutic modalities and acuity profile.

Broad incumbents

• LifeStance Health: Large outpatient mental health platform operating psychiatric and therapy practices across the U.S. Comparable outpatient mental health service line and insurance-reimbursement model at significantly greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/NeuroscienceRe1
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/neuroscience-research-institute-mental-health-center

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neuroscience Institute